# Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea

> **NCT03892772** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 23 (actual)

## Conditions studied

- Sleep Apnea

## Interventions

- **DRUG:** SAS0421a
- **DRUG:** SAS0421b
- **DRUG:** SAS0421c
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03892772
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-14
- **Primary completion:** 2021-07-03
- **Final completion:** 2021-07-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03892772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03892772, "Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03892772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*